FOLD logo

Amicus Therapeutics, Inc. (FOLD) Revenue

Annual revenue:

$528.29M+$128.94M(+32.29%)
December 31, 2024

Summary

  • As of today (September 17, 2025), FOLD annual revenue is $528.29 million, with the most recent change of +$128.94 million (+32.29%) on December 31, 2024.
  • During the last 3 years, FOLD annual revenue has risen by +$222.78 million (+72.92%).
  • FOLD annual revenue is now at all-time high.

Performance

FOLD Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Quarterly revenue:

$154.69M+$29.44M(+23.50%)
June 30, 2025

Summary

  • As of today (September 17, 2025), FOLD quarterly revenue is $154.69 million, with the most recent change of +$29.44 million (+23.50%) on June 30, 2025.
  • Over the past year, FOLD quarterly revenue has increased by +$28.02 million (+22.12%).
  • FOLD quarterly revenue is now at all-time high.

Performance

FOLD Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

TTM revenue:

$571.16M+$28.02M(+5.16%)
June 30, 2025

Summary

  • As of today (September 17, 2025), FOLD TTM revenue is $571.16 million, with the most recent change of +$28.02 million (+5.16%) on June 30, 2025.
  • Over the past year, FOLD TTM revenue has increased by +$115.50 million (+25.35%).
  • FOLD TTM revenue is now at all-time high.

Performance

FOLD TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

FOLD Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.3%+22.1%+25.4%
3 y3 years+72.9%+91.6%+77.8%
5 y5 years+189.9%+148.1%+151.7%

FOLD Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+72.9%at high+91.6%at high+77.8%
5 y5-yearat high+189.9%at high+148.1%at high+151.7%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

FOLD Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$154.69M(+23.5%)
$571.16M(+5.2%)
Mar 2025
-
$125.25M(-16.3%)
$543.14M(+2.8%)
Dec 2024
$528.29M(+32.3%)
$149.71M(+5.8%)
$528.29M(+7.0%)
Sep 2024
-
$141.52M(+11.7%)
$493.67M(+8.3%)
Jun 2024
-
$126.67M(+14.7%)
$455.65M(+7.6%)
Mar 2024
-
$110.40M(-4.1%)
$423.49M(+6.0%)
Dec 2023
$399.36M(+21.3%)
$115.08M(+11.2%)
$399.36M(+7.2%)
Sep 2023
-
$103.50M(+9.5%)
$372.37M(+6.2%)
Jun 2023
-
$94.50M(+9.5%)
$350.56M(+4.1%)
Mar 2023
-
$86.27M(-2.1%)
$336.79M(+2.3%)
Dec 2022
$329.23M(+7.8%)
$88.10M(+7.8%)
$329.23M(+1.8%)
Sep 2022
-
$81.69M(+1.2%)
$323.29M(+0.7%)
Jun 2022
-
$80.73M(+2.6%)
$321.14M(+1.0%)
Mar 2022
-
$78.72M(-4.2%)
$317.83M(+4.0%)
Dec 2021
$305.51M(+17.1%)
$82.15M(+3.3%)
$305.51M(+3.9%)
Sep 2021
-
$79.55M(+2.8%)
$293.93M(+4.3%)
Jun 2021
-
$77.41M(+16.6%)
$281.82M(+5.6%)
Mar 2021
-
$66.40M(-5.9%)
$266.76M(+2.3%)
Dec 2020
$260.89M(+43.2%)
$70.57M(+4.6%)
$260.89M(+6.2%)
Sep 2020
-
$67.44M(+8.2%)
$245.61M(+8.2%)
Jun 2020
-
$62.35M(+3.0%)
$226.94M(+8.7%)
Mar 2020
-
$60.52M(+9.5%)
$208.72M(+14.5%)
Dec 2019
$182.24M(+99.7%)
$55.29M(+13.4%)
$182.24M(+14.2%)
Sep 2019
-
$48.77M(+10.5%)
$159.59M(+21.4%)
Jun 2019
-
$44.13M(+29.6%)
$131.42M(+21.0%)
Mar 2019
-
$34.05M(+4.3%)
$108.59M(+19.0%)
Dec 2018
$91.25M(+147.1%)
$32.64M(+58.5%)
$91.25M(+24.4%)
Sep 2018
-
$20.60M(-3.3%)
$73.33M(+15.3%)
Jun 2018
-
$21.31M(+27.6%)
$63.61M(+28.6%)
Mar 2018
-
$16.70M(+13.4%)
$49.46M(+33.9%)
Dec 2017
$36.93M(+644.9%)
$14.73M(+35.5%)
$36.93M(+47.5%)
Sep 2017
-
$10.87M(+51.9%)
$25.03M(+53.7%)
Jun 2017
-
$7.16M(+71.7%)
$16.29M(+78.4%)
Mar 2017
-
$4.17M(+47.3%)
$9.13M(+84.1%)
Dec 2016
$4.96M(>+9900.0%)
$2.83M(+33.1%)
$4.96M(+133.1%)
Sep 2016
-
$2.13M(>+9900.0%)
$2.13M(>+9900.0%)
Jun 2016
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2015
$0.00
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Sep 2015
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2015
-
$0.00(0.0%)
$293.00K(-61.8%)
Mar 2015
-
$0.00(0.0%)
$768.00K(-37.3%)
Dec 2014
$1.22M(+237.2%)
$0.00(-100.0%)
$1.22M(-20.9%)
Sep 2014
-
$293.00K(-38.3%)
$1.55M(+19.6%)
Jun 2014
-
$475.00K(+4.2%)
$1.29M(+58.0%)
Mar 2014
-
$456.00K(+40.7%)
$819.00K(+125.6%)
Dec 2013
$363.00K(-98.0%)
$324.00K(+730.8%)
$363.00K(+830.8%)
Sep 2013
-
$39.00K(>+9900.0%)
$39.00K(>+9900.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2013
-
$0.00(0.0%)
$10.64M(-42.2%)
Dec 2012
$18.41M(-14.1%)
$0.00(0.0%)
$18.41M(-23.4%)
Sep 2012
-
$0.00(-100.0%)
$24.04M(-19.4%)
Jun 2012
-
$10.64M(+36.8%)
$29.84M(+28.4%)
Mar 2012
-
$7.77M(+38.1%)
$23.24M(+8.4%)
Dec 2011
$21.43M(+2224.7%)
$5.63M(-2.9%)
$21.43M(+28.1%)
Sep 2011
-
$5.80M(+43.5%)
$16.73M(+53.1%)
Jun 2011
-
$4.04M(-32.3%)
$10.93M(+58.7%)
Mar 2011
-
$5.97M(+547.1%)
$6.89M(+647.1%)
Dec 2010
$922.00K(-98.6%)
$922.00K(>+9900.0%)
$922.00K(-98.1%)
Sep 2010
-
$0.00(0.0%)
$49.48M(-9.0%)
Jun 2010
-
$0.00(0.0%)
$54.39M(-9.0%)
Mar 2010
-
$0.00(-100.0%)
$59.75M(-7.2%)
Dec 2009
$64.36M(+330.0%)
$49.48M(+907.0%)
$64.36M(+234.8%)
Sep 2009
-
$4.91M(-8.4%)
$19.23M(+7.0%)
Jun 2009
-
$5.36M(+16.4%)
$17.96M(+9.5%)
Mar 2009
-
$4.61M(+6.0%)
$16.41M(+9.7%)
Dec 2008
$14.97M(+739.0%)
$4.34M(+18.9%)
$14.96M(+20.6%)
Sep 2008
-
$3.65M(-4.0%)
$12.40M(+41.7%)
Jun 2008
-
$3.81M(+20.5%)
$8.75M(+77.0%)
Mar 2008
-
$3.16M(+77.1%)
$4.94M(+177.1%)
Dec 2007
$1.78M(>+9900.0%)
$1.78M(>+9900.0%)
$1.78M(>+9900.0%)
Sep 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2006
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
$0.00(0.0%)
$0.00
$0.00
Dec 2004
$0.00(0.0%)
-
-
Dec 2003
$0.00
-
-

FAQ

  • What is Amicus Therapeutics, Inc. annual revenue?
  • What is the all time high annual revenue for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual revenue year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly revenue?
  • What is the all time high quarterly revenue for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly revenue year-on-year change?
  • What is Amicus Therapeutics, Inc. TTM revenue?
  • What is the all time high TTM revenue for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. TTM revenue year-on-year change?

What is Amicus Therapeutics, Inc. annual revenue?

The current annual revenue of FOLD is $528.29M

What is the all time high annual revenue for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual revenue is $528.29M

What is Amicus Therapeutics, Inc. annual revenue year-on-year change?

Over the past year, FOLD annual revenue has changed by +$128.94M (+32.29%)

What is Amicus Therapeutics, Inc. quarterly revenue?

The current quarterly revenue of FOLD is $154.69M

What is the all time high quarterly revenue for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly revenue is $154.69M

What is Amicus Therapeutics, Inc. quarterly revenue year-on-year change?

Over the past year, FOLD quarterly revenue has changed by +$28.02M (+22.12%)

What is Amicus Therapeutics, Inc. TTM revenue?

The current TTM revenue of FOLD is $571.16M

What is the all time high TTM revenue for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high TTM revenue is $571.16M

What is Amicus Therapeutics, Inc. TTM revenue year-on-year change?

Over the past year, FOLD TTM revenue has changed by +$115.50M (+25.35%)
On this page